Qitong Chen
Overview
Explore the profile of Qitong Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hong Y, Peng J, Chen Q, Zhou Q, Xu F, Yao J, et al.
Ther Adv Med Oncol
. 2024 Sep;
16:17588359241279695.
PMID: 39346118
Background: Pegylated liposomal doxorubicin (PLD), epirubicin and pirarubicin are the main anthracyclines widely used in China. PLD demonstrates therapeutic response comparable to epirubicin and pirarubicin in neoadjuvant chemotherapy (NAC) of...
2.
Chen X, Yin H, Chen Q, Chen L, Shen C
ISA Trans
. 2024 Aug;
154:389-406.
PMID: 39179484
Extensive researches have been conducted on transfer learning based fault diagnosis. However, negative information transfer may arise due to significant differences in the subdomain distribution across multiple source domains (MSDs)....
3.
Gao H, Zhu J, Wu T, Long Q, Guan X, Chen Q, et al.
Apoptosis
. 2024 Aug;
29(11-12):2128-2146.
PMID: 39097858
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is a crucial enzyme involved in phospholipid metabolism and is essential for maintaining the structure and functionality of biofilms. However, a comprehensive examination of the role...
4.
Qu L, Mei X, Yi Z, Zou Q, Zhou Q, Zhang D, et al.
Int J Surg
. 2024 Jun;
110(9):5363-5373.
PMID: 38847776
Background: The accuracy of traditional clinical methods for assessing the metastatic status of axillary lymph nodes (ALNs) is unsatisfactory. In this study, the authors propose the use of radiomic technology...
5.
Chen Q, Zhou Q
Heliyon
. 2024 Apr;
10(8):e29551.
PMID: 38665551
Background: Exosomes are promising tools for the development of new diagnostic and therapeutic approaches. Exosomes possess the ability to activate signaling pathways that contribute to the remodeling of the tumor...
6.
Peng J, Hong Y, Chen Q, Xu F, Zhang D, Yao J, et al.
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1347762.
PMID: 38567311
Objective: Hormone receptor (HR)-low/HER2-negative breast cancers (BCs) are more likely to be basal-like BCs, with similar molecular features and gene expression profiles to HR-negative (estrogen receptor <1% or negative and...
7.
Duan Z, Liang Y, Sun J, Zheng H, Lin T, Luo P, et al.
Innovation (Camb)
. 2024 Feb;
5(2):100564.
PMID: 38379787
The type V-I CRISPR-Cas system is becoming increasingly more attractive for genome editing. However, natural nucleases of this system often exhibit low efficiency, limiting their application. Here, we used structure-guided...
8.
Gao H, Ouyang D, Guan X, Xu J, Chen Q, Zeng L, et al.
BMC Cancer
. 2024 Jan;
24(1):50.
PMID: 38195475
Background: In the context of breast cancer (BC), the correlation between lymphocytes and clinical outcomes, along with treatment response, has garnered attention. Despite this, few investigations have delved into the...
9.
Chen Q, Qu L, He Y, Deng Y, Zhou Q, Yi W
Front Endocrinol (Lausanne)
. 2023 Dec;
14:1222651.
PMID: 38053723
Background: The frequency of nipple-sparing mastectomy (NSM) surgery is presently increasing. Nonetheless, there is a paucity of long-term prognosis data on NSM. This study compared the long-standing prognosis of NSM...
10.
Zhu J, Chen Q, Zeng L, Gao H, Wu T, He Y, et al.
Front Immunol
. 2023 Oct;
14:1236806.
PMID: 37901236
Background: Origin recognition complex 6 () is one of the six highly conserved subunit proteins required for DNA replication and is essential for maintaining genome stability during cell division. Recent...